1,2-dichloroethane increases expression ISO RGD:1322950 6480464 ethylene dichloride results in increased expression of SPRY2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:1322950 6480464 1, 2-Dimethylhydrazine affects the expression of SPRY2 mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1322949 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322950 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SPRY2 promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SPRY2 mRNA CTD PMID:21215274 2-methylcholine affects expression ISO RGD:1322949 6480464 beta-methylcholine affects the expression of SPRY2 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1322950 6480464 Methylcholanthrene results in increased expression of SPRY2 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1322950 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SPRY2 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1322949 6480464 4-hydroxy-2-nonenal results in decreased expression of SPRY2 mRNA CTD PMID:12419474 8-Br-cAMP increases expression ISO RGD:1322949 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRY2 mRNA CTD PMID:22079614 acetaldehyde affects expression ISO RGD:1322950 6480464 Acetaldehyde affects the expression of SPRY2 mRNA CTD PMID:22634333 aldehydo-D-glucose increases expression ISO RGD:1322950 6480464 Glucose results in increased expression of SPRY2 mRNA CTD PMID:17178593 all-trans-retinoic acid affects expression ISO RGD:1322949 6480464 Tretinoin affects the expression of SPRY2 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases expression ISO RGD:1322949 6480464 Tretinoin results in decreased expression of SPRY2 mRNA CTD PMID:23724009 arsane affects methylation ISO RGD:1322949 6480464 Arsenic affects the methylation of SPRY2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1322949 6480464 Arsenic affects the methylation of SPRY2 gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:1322949 6480464 arsenite results in decreased expression of SPRY2 protein CTD PMID:22387281 atrazine decreases expression ISO RGD:1322949 6480464 Atrazine results in decreased expression of SPRY2 mRNA CTD PMID:22378314 bisphenol A affects expression ISO RGD:1322949 6480464 bisphenol A affects the expression of SPRY2 mRNA CTD PMID:20170705 bisphenol A decreases expression ISO RGD:1322949 6480464 bisphenol A results in decreased expression of SPRY2 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SPRY2 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SPRY2 mRNA CTD PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SPRY2 mRNA CTD PMID:25181051 calcitriol increases expression ISO RGD:1322949 6480464 Calcitriol results in increased expression of SPRY2 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1322950 6480464 Carbamazepine affects the expression of SPRY2 mRNA CTD PMID:22634333 cisplatin multiple interactions ISO RGD:1322949 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SPRY2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1322949 6480464 Cisplatin results in decreased expression of SPRY2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1322949 6480464 cobaltous chloride results in decreased expression of SPRY2 mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO RGD:1322949 6480464 Copper Sulfate results in decreased expression of SPRY2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1322949 6480464 Asbestos, Crocidolite results in increased expression of SPRY2 mRNA CTD PMID:18687144 crocidolite asbestos increases methylation ISO RGD:1322949 6480464 Asbestos, Crocidolite results in increased methylation of SPRY2 gene CTD PMID:29523930 crocidolite asbestos affects expression ISO RGD:1322949 6480464 Asbestos, Crocidolite affects the expression of SPRY2 mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:1322949 6480464 Cyclosporine results in increased expression of SPRY2 mRNA CTD PMID:20106945 cyproconazole decreases expression ISO RGD:1322950 6480464 cyproconazole results in decreased expression of SPRY2 mRNA CTD PMID:22045034 D-glucose increases expression ISO RGD:1322950 6480464 Glucose results in increased expression of SPRY2 mRNA CTD PMID:17178593 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SPRY2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1322950 6480464 Dibutyl Phthalate results in increased expression of SPRY2 mRNA CTD PMID:17361019 , PMID:21266533 dioxygen multiple interactions ISO RGD:1322949 6480464 Oxygen deficiency promotes the reaction [KDM3A protein binds to SPRY2 promoter] CTD PMID:20881000 dioxygen decreases expression ISO RGD:1322949 6480464 Oxygen deficiency results in decreased expression of SPRY2 mRNA, Oxygen deficiency results in decreased expression of SPRY2 protein CTD PMID:20881000 ethanol affects expression ISO RGD:1322950 6480464 Ethanol affects the expression of SPRY2 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1322949 6480464 Ethyl Methanesulfonate results in decreased expression of SPRY2 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:1322950 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY2 mRNA CTD PMID:28329830 fluoxetine affects expression ISO RGD:1322950 6480464 Fluoxetine affects the expression of SPRY2 mRNA CTD PMID:29893963 flusilazole affects expression ISO RGD:1322950 6480464 flusilazole affects the expression of SPRY2 mRNA CTD PMID:22634333 formaldehyde decreases expression ISO RGD:1322949 6480464 Formaldehyde results in decreased expression of SPRY2 mRNA CTD PMID:20655997 furan increases expression EXP 6480464 furan results in increased expression of SPRY2 mRNA CTD PMID:27387713 glucose increases expression ISO RGD:1322950 6480464 Glucose results in increased expression of SPRY2 mRNA CTD PMID:17178593 hydrogen peroxide affects expression ISO RGD:1322949 6480464 Hydrogen Peroxide affects the expression of SPRY2 mRNA CTD PMID:20044591 hydrogen peroxide decreases expression ISO RGD:1322949 6480464 Hydrogen Peroxide results in decreased expression of SPRY2 mRNA CTD PMID:12419474 isobutanol multiple interactions ISO RGD:1322949 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SPRY2 mRNA CTD PMID:29432896 lead diacetate decreases expression ISO RGD:1322950 6480464 lead acetate results in decreased expression of SPRY2 mRNA CTD PMID:22609695 leflunomide increases expression ISO RGD:1322949 6480464 leflunomide results in increased expression of SPRY2 mRNA CTD PMID:28988120 menadione affects expression ISO RGD:1322949 6480464 Vitamin K 3 affects the expression of SPRY2 mRNA CTD PMID:20044591 menadione decreases expression ISO RGD:1322950 6480464 Vitamin K 3 results in decreased expression of SPRY2 mRNA CTD PMID:25270620 methyl methanesulfonate decreases expression ISO RGD:1322949 6480464 Methyl Methanesulfonate results in decreased expression of SPRY2 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:1322949 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SPRY2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1322949 6480464 methylmercuric chloride results in increased expression of SPRY2 mRNA CTD PMID:28001369 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of SPRY2 mRNA CTD PMID:17412507 N-nitrosodiethylamine increases expression ISO RGD:1322950 6480464 Diethylnitrosamine results in increased expression of SPRY2 mRNA CTD PMID:24535843 nickel atom multiple interactions ISO RGD:1322949 6480464 SPRY2 mRNA affects the reaction [Nickel results in increased phosphorylation of MAPK1 protein] more ... CTD PMID:20881000 nickel atom decreases expression ISO RGD:1322949 6480464 Nickel results in decreased expression of SPRY2 mRNA, Nickel results in decreased expression of SPRY2 protein CTD PMID:20881000 nickel dichloride multiple interactions ISO RGD:1322949 6480464 3-4-methylphenylsulfonyl-2-propenenitrile inhibits the reaction [nickel chloride results in decreased expression of SPRY2 protein] more ... CTD PMID:26026961 nickel dichloride decreases expression ISO RGD:1322949 6480464 nickel chloride results in decreased expression of SPRY2 protein CTD PMID:26026961 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SPRY2 mRNA CTD PMID:23982388 , PMID:24210189 nitrofen multiple interactions EXP 6480464 nitrofen results in decreased expression of and results in decreased phosphorylation of SPRY2 protein CTD PMID:24210189 paracetamol affects expression ISO RGD:1322950 6480464 Acetaminophen affects the expression of SPRY2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1322949 6480464 Acetaminophen results in increased expression of SPRY2 mRNA CTD PMID:26690555 , PMID:29067470 PD 0325901 multiple interactions ISO RGD:1322949 6480464 [PD 0325901 co-treated with +-JQ1 compound] results in decreased expression of SPRY2 mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:1322949 6480464 PD 0325901 results in decreased expression of SPRY2 mRNA CTD PMID:25119042 phenobarbital affects expression ISO RGD:1322949 6480464 Phenobarbital affects the expression of SPRY2 mRNA CTD PMID:19159669 phorone affects expression EXP 6480464 phorone affects the expression of SPRY2 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:1322950 6480464 pirinixic acid results in increased expression of SPRY2 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:1322949 6480464 potassium chromateVI results in decreased expression of SPRY2 mRNA CTD PMID:22714537 silver atom decreases expression ISO RGD:1322950 6480464 Silver results in decreased expression of SPRY2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1322950 6480464 Silver results in decreased expression of SPRY2 mRNA CTD PMID:27131904 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SPRY2 mRNA CTD PMID:19072884 Soman increases expression EXP 6480464 Soman results in increased expression of SPRY2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1322949 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPRY2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:1322949 6480464 Sunitinib results in increased expression of SPRY2 mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:1322949 6480464 tamibarotene results in increased expression of SPRY2 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:1322950 6480464 Tamoxifen affects the expression of SPRY2 mRNA CTD PMID:20937368 taurine increases expression ISO RGD:1322949 6480464 Taurine results in increased expression of SPRY2 mRNA CTD PMID:16579726 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of SPRY2 mRNA CTD PMID:21515302 thapsigargin decreases expression ISO RGD:1322949 6480464 Thapsigargin results in decreased expression of SPRY2 mRNA CTD PMID:22378314 torcetrapib increases expression ISO RGD:1322949 6480464 torcetrapib results in increased expression of SPRY2 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1322949 6480464 trichostatin A results in decreased expression of SPRY2 mRNA CTD PMID:26272509 trimellitic anhydride decreases expression ISO RGD:1322950 6480464 trimellitic anhydride results in decreased expression of SPRY2 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:1322949 6480464 Tunicamycin results in decreased expression of SPRY2 mRNA CTD PMID:22378314 , PMID:29453283 urethane increases expression ISO RGD:1322949 6480464 Urethane results in increased expression of SPRY2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1322950 6480464 Valproic Acid results in decreased expression of SPRY2 mRNA CTD PMID:21427059 , PMID:22045034 valproic acid decreases expression ISO RGD:1322949 6480464 Valproic Acid results in decreased expression of SPRY2 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:1322949 6480464 Valproic Acid results in increased expression of SPRY2 mRNA CTD PMID:24935251 , PMID:28001369 valproic acid affects expression ISO RGD:1322949 6480464 Valproic Acid affects the expression of SPRY2 mRNA CTD PMID:25979313 valsartan multiple interactions ISO RGD:1322949 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of SPRY2 mRNA] CTD PMID:19225232 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SPRY2 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1322949 6480464 vorinostat results in decreased expression of SPRY2 mRNA CTD PMID:27188386